5 June 2026

Semaglutide Reduces Asthma-Related Adverse Outcomes in Patients With Comorbid Asthma and Obesity: A Post Hoc Analysis of the SELECT Trial

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.

Keywords

Obesity

Congress poster

GLP-1 RA

Semaglutide

PHASE 3 (RCT)